Significados del consumo de marihuana por personas diagnosticadas con esquizofrenia
DOI:
https://doi.org/10.34019/1982-1247.2024.v18.36116Palabras clave:
marihuana, esquizofrenia, estudio cualitativoResumen
Este estudio tuvo como objetivo analizar los significados atribuidos al consumo de marihuana por personas diagnosticadas con esquizofrenia. Se trata de un estudio cualitativo, con personas en tratamiento en un servicio público especializado en drogas. Entre los significados, se identificaron: 1) Para algunas personas, el uso significa la posibilidad de experimentar placer y bienestar; 2) También se identificaron discursos sobre la influencia del consumo en la aparición y empeoramiento de los sintomas. 3) Otros se referían a las consecuencias sociales y la ruptura de los lazos familiares y laborales. 4) Además, el uso estaría asociado a la discriminación y ilegalidad.
Descargas
Citas
Asher, C. J., & Gask, L. (2010). Reasons for illicit drug use in people with schizophrenia: qualitative study. BioMed Central Psychiatry, 10(94), 1-15. doi: 10.1186/1471-244X-10-94.
Becker, H. S. (2008). Outsiders: estudos de sociologia do desvio. Rio de Janeiro, Zahar.
Bechtold, J., Hipwell, A., Lewis, D. A., Loeber, R., & Pardini, D. (2016). Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms. American Journal of Psychiatry, 173(8), 781–789. doi:10.1176/appi.ajp.2016.15070878
Braun, V., & Clarke, V. (2021). Conceptual and design thinking for thematic analysis. Qualitative Psychology. Advance online publication. doi: https://doi.org/10.1037/qup0000196
Clarke, V., & Braun, V. (2013) Successful qualitative research: A practical guide for beginners. London: Sage.
Buadze, A., Stohler, R., Schulze, B., Schaub, M., & Liebrenz, M. (2010). Do patients think cannabis causes schizophrenia? A qualitative study on the causal beliefs of cannabis using patinets with schizophrenia. Harm Reduction Journal, 7(22), 1-8. doi: 10.1186/1477-7517-7-22.
Childs, H. E., Mccarthy-Jones, S., Rowse, G., & Turpim, G. (2011). The journey through cannabis use a qualitative study of the experiences of young adults with psychosis. The Journal of Nervous and Mental Disease, 199(9), 703-708. doi: 10.1097/NMD.0b013e318229d6bd.
Copello, A., Clutterbuck, R., Tobin, D., Orford, J., Preece, M., Birchwood, M., & McGovern, D. (2009). Exploring the attitudes of staff working within mental health settings toward clients who use cannabis. Birmingham & Solihull Mental Health Trust, 16(4), 311-329. doi: 10.1080/09687630801945861.
Corradi-Webster, C. M., Melo, M. C., Leão, E. A., & Vieira, F. S. (2017). Saúde mental e uso de drogas: possibilidades para o cuidado. In: R. M. S. Seabra, (Org.). Boas práticas: caminhos e descaminhos no processo de desinstitucionalização. (1st ed., pp. 181-207) São Paulo: Cultura Acadêmica – UNESP.
Costain, W. F. (2008). The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. International Journal of Mental Health Nursing, 17, 227–235. doi: 10.1111/j.1447-0349.2008.00538.x.
Degenhardt, L., Saha, S., Lim, C. C. W., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., & World Mental Health Survey Collaborators. (2017). The associations between psychotic experiences, and substance use and substance use disorders: Findings from the World Health Organization - World Mental Health Surveys. Addiction. doi: 10.1111/add.14145.
D’Souza, D. C., Sewell, R. A., Ranganathan, M. (2009). Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry Clinical Neuroscience, 259(7), 413–31.
Gill, K. E., Poe, L., Azimov, N., Ben‐David, S., Vadhan, N. P., Girgis, R., & Corcoran, C. M. (2015). Reasons for cannabis use among youths at ultra-high risk for psychosis. Early Intervention in Psychiatry, 9(3), 207-210.
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016). Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the national epidemiologic survey on alcohol and related conditions–III. Am J Psychiatry, 173, 588–599
Katz, G., Durst, R., Shufman, E., Bar-Hamburger, R., & Grunhaus, L. (2010). Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Comprehensive Psychiatry, 51, 37–41. doi: 10.1016/j.comppsych.2009.03.008.
Kolliakou, A., Joseph, C., Ismail, K., Atakan, Z., & Murray, R. M. (2011). Why do patients with psychosis use cannabis and are they ready to change their use? International Journal of Developmental Neuroscience, 29(3), 335-46. doi: 10.1016/j.ijdevneu.2010.11.006.
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Rate of Cannabis Use Disorders in Clinical Samples of Patients with Schizophrenia: A Meta-analysis. Schizophrenia Bulletin, 36(6), 1115– 130. doi:10.1093/schbul/sbp031
Lafaye, G., Karila, L., Blecha, L., & Benyamina, A. (2017). Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience, 19(3), 309-316.
Lobbana, F., Barrowclough, C., Jeffery, S., Bucci, S., Taylor, K., Mallinson, S., & Marshall, M. (2010). Understanding factors influencing substance use in people with recent onset psychosis: A qualitative study. Social Science & Medicine, 70, 1141–1147. doi: 10.1016/j.socscimed.2009.12.026.
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia Bulletin, 42(5), 1262–1269. doi:10.1093/schbul/sbw003
Matheson, S. L., Shepherd, A. M., Laurens, K. R., & Carr, V. J. (2011). A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res, 133(1-3):133–42
Nutt, D. (2012). Drugs without the hot air – minimizing the harms of legal and illegal drugs. UIT, Cambridge, England.
Parshotam, R. K., & Joubert, P. M. (2015). Views of schizophrenia patients on the effects of cannabis on their mental health. South African Journal of Psychiatry, 21, 57.
Pettersen, H., et al. (2013). Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness. Int J of Qual Stud on Health and Well-Being, 8(10), 21968.
Rabin, R. A., & George, T. P. (2017). Understanding the Link Between Cannabinoids and Psychosis. Clinical Pharmacology & Therapeutics, 101(2), 197-199. doi: 10.1002/cpt.421
Seddon, J. L., Copello, A., & Birchwood, M. (2013) Cannabis use and abstention in first-episode psychosis: the participants' view. Mental Health and Substance Use, 6(1), 47-58, doi: 10.1080/17523281.2012.660190
Schneider, J. (2011). Experiências de ruptura de usuários de drogas. Soc. E Cult., 14 (2), 311-320. doi: 10.5216/sec.v14i2.17607
Siqueira, D. F., et al. (2016). Familiar do usuário de substâncias psicoativas: revisão de literatura. Multiciência online. ISSN 2448-4148. Retrieved from: http://www.urisantiago.br/multicienciaonline/adm/upload/v3/n5/02fe22060bbb9f546f81229f7228e6f9.pdf
Souza, J., Kantorski, L., & Mielke, F. (2006). Vínculos e redes sociais de indivíduos dependentes de substâncias psicoativas sob tratamento em CAPS AD. SMAD Revista Eletrônica Saúde Mental Álcool E Drogas (Edição Em Português), 2(1), 01-17.
Sutovic, A. (2017). Psychiatry between Glorification and Stigmatization. Psychiatria Danubina, 29(5), 880-884.
Tong, A., Craig, J., & Sainsbury, P. (2007). Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349 –357. doi: https://doi.org/10.1093/intqhc/mzm042
Wagstaff, C., Graham, H., Farrell, D., Larkin, M., & Tatham, L. (2017). Perspectives of cannabis use in the life experience of men with schizophrenia. International Journal of Mental Health Nursing, 8(1), 1–11. doi: 10.1111/inm.12422.
World Health Organization. (2016). The Health and Social Effects of Nonmedical Cannabis Use. Geneva: World Health Organization. Retrieved from: https://www.who.int/substance_abuse/publications/msbcannabis.pdf
World Health Organization. (2019). World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.8). Retrieved from: https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_5_CANNABIS_HALLUCINOGENS.pdf
